What precautions are necessary for someone taking isotretinoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Essential Precautions for Patients Taking Isotretinoin

Patients taking isotretinoin must strictly adhere to the iPLEDGE REMS program requirements, with pregnancy prevention being the most critical precaution due to the severe risk of birth defects. 1

Pregnancy Prevention Requirements

  • All patients must enroll in the iPLEDGE REMS program before starting isotretinoin 1

  • For patients who can become pregnant:

    • Must have two negative pregnancy tests before starting therapy 1
    • Must use two effective forms of contraception simultaneously for one month before, during, and for one month after treatment (unless committing to complete abstinence) 1
    • Monthly pregnancy tests are required during treatment 2, 1
    • Must obtain prescriptions within 7 days of pregnancy test specimen collection 1
  • For all patients:

    • Must not donate blood during treatment and for at least 1 year after discontinuation 1
    • Must not share medication with anyone 1

Laboratory Monitoring

  • Baseline tests before starting isotretinoin:

    • Liver function tests (ALT, AST, alkaline phosphatase, bilirubin) 2
    • Fasting lipid panel (cholesterol, triglycerides) 2
    • Pregnancy test for patients who can become pregnant 2, 1
  • Ongoing monitoring:

    • Repeat liver function tests and lipid panel at least once during treatment, typically after 2 months 2, 3
    • Monthly pregnancy tests for patients who can become pregnant 2, 1
    • Routine complete blood count monitoring is not necessary in healthy patients 2, 3

Medication Interactions

  • Avoid concurrent use of:

    • Tetracycline antibiotics (risk of pseudotumor cerebri/intracranial hypertension) 2
    • Vitamin A supplements (increased risk of vitamin A toxicity) 2
    • Methotrexate (increased risk of liver toxicity) 2
    • Alcohol (may increase metabolism of isotretinoin to etretinate, extending the teratogenic risk period) 2
  • Use with caution with:

    • Phenytoin (isotretinoin may reduce protein binding) 2
    • Antidiabetic medications (increased risk of hypoglycemia) 2
    • Corticosteroids (increased risk of hyperlipidemia) 2

Dermatologic Precautions

  • Avoid excessive sun exposure and use sunscreen due to increased photosensitivity 2
  • Avoid waxing for hair removal as retinoids cause skin fragility 2
  • Use liberal emollients for management of mucocutaneous dryness, which affects almost all patients 2
  • Be aware of increased risk of minor skin infections (folliculitis, furunculosis) due to higher rates of S. aureus colonization 2

Mental Health Monitoring

  • Patients and family members should be informed about monitoring for signs of depression, mood changes, or suicidal thoughts 1
  • Signs of depression include sad mood, hopelessness, feelings of guilt, worthlessness, fatigue, difficulty concentrating, changes in sleep patterns or appetite, and suicidal thoughts 1
  • Discontinue isotretinoin and contact the prescriber promptly if depression, mood disturbance, psychosis, or aggression develops 1

Special Considerations

  • Elective cosmetic procedures (dermabrasion, laser resurfacing) should generally be delayed for 6-12 months after discontinuing isotretinoin 2
  • Patients with diabetes should have more frequent monitoring of blood glucose levels 2
  • Patients with a history of bone disorders or those on medications affecting bone metabolism should be monitored carefully 1
  • Patients should avoid participation in sports with repetitive impact due to potential risk of fractures or delayed healing 1

Following these precautions is essential to minimize risks while maximizing the therapeutic benefits of isotretinoin for treating severe, recalcitrant acne.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Standardized laboratory monitoring with use of isotretinoin in acne.

Journal of the American Academy of Dermatology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.